UiPath (NYSE:PATH) Stock Rating Reaffirmed by TD Cowen

TD Cowen reaffirmed their hold rating on shares of UiPath (NYSE:PATH) in a report published on Thursday morning, MarketBeat reports. The brokerage currently has a $17.00 price objective on the healthcare company’s stock, down from their prior price objective of $28.00.

Several other equities research analysts have also commented on PATH. Needham & Company LLC reiterated a hold rating on shares of UiPath in a research report on Thursday. Scotiabank decreased their price objective on shares of UiPath from $30.00 to $25.00 and set a sector perform rating on the stock in a research report on Wednesday, May 29th. Truist Financial reiterated a hold rating and issued a $14.00 price objective (down from $32.00) on shares of UiPath in a research report on Thursday. Barclays boosted their price objective on shares of UiPath from $23.00 to $25.00 and gave the stock an equal weight rating in a research report on Friday, March 15th. Finally, Morgan Stanley boosted their price objective on shares of UiPath from $17.00 to $25.00 and gave the stock an equal weight rating in a research report on Thursday, March 14th. Fifteen research analysts have rated the stock with a hold rating and three have issued a buy rating to the company. According to data from MarketBeat, the company has a consensus rating of Hold and a consensus price target of $19.59.

UiPath Stock Up 1.6 %

NYSE:PATH opened at $12.26 on Thursday. UiPath has a fifty-two week low of $11.71 and a fifty-two week high of $27.87. The stock has a market cap of $6.98 billion, a PE ratio of -76.63 and a beta of 1.01. The firm’s fifty day simple moving average is $19.92 and its 200-day simple moving average is $22.08.

UiPath (NYSE:PATH) last posted its quarterly earnings results on Wednesday, March 13th. The healthcare company reported $0.06 earnings per share for the quarter, topping analysts’ consensus estimates of ($0.04) by $0.10. UiPath had a negative net margin of 6.41% and a negative return on equity of 2.99%. The business had revenue of $405.25 million for the quarter, compared to analysts’ expectations of $383.32 million. Equities analysts anticipate that UiPath will post -0.04 earnings per share for the current year.

Insider Activity

In other news, CFO Ashim Gupta sold 40,000 shares of the company’s stock in a transaction dated Thursday, April 4th. The shares were sold at an average price of $21.66, for a total transaction of $866,400.00. Following the completion of the transaction, the chief financial officer now owns 660,762 shares of the company’s stock, valued at approximately $14,312,104.92. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Insiders sold a total of 96,000 shares of company stock valued at $2,023,440 in the last 90 days. 22.37% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Principal Financial Group Inc. increased its position in UiPath by 3.9% during the 3rd quarter. Principal Financial Group Inc. now owns 42,529 shares of the healthcare company’s stock worth $728,000 after purchasing an additional 1,586 shares in the last quarter. Private Advisor Group LLC acquired a new stake in UiPath during the 3rd quarter worth approximately $171,000. Victory Capital Management Inc. increased its position in UiPath by 11.2% during the 3rd quarter. Victory Capital Management Inc. now owns 45,240 shares of the healthcare company’s stock worth $774,000 after purchasing an additional 4,554 shares in the last quarter. Arizona State Retirement System increased its position in UiPath by 0.8% during the 3rd quarter. Arizona State Retirement System now owns 97,951 shares of the healthcare company’s stock worth $1,676,000 after purchasing an additional 733 shares in the last quarter. Finally, Qsemble Capital Management LP acquired a new stake in UiPath during the 3rd quarter worth approximately $1,417,000. Institutional investors and hedge funds own 62.50% of the company’s stock.

About UiPath

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.